Akt/protein kinase B in skeletal muscle physiology and pathology

Journal of Cellular Physiology

Volumn 226, Issue 1, 2011, Pages 29-36

  Wu, Miaozong ^a   Falasca, Marco ^b   Blough, Eric R ^a,c  

^a MARSHALL UNIVERSITY   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN KINASE B;

CELL SURVIVAL; ENZYME ACTIVITY; GENETIC ANALYSIS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; LIFESPAN; MUSCLE ATROPHY; MUSCLE CANCER; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE STRESS; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN SYNTHESIS; REVIEW; SKELETAL MUSCLE;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 78049257383     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22353     Document Type: Review

References (99)

1. Alessi DR, Deak M, Casamayor A, Caudwell FB, Morrice N, Norman DG, Gaffney P, Reese CB, MacDougall CN, Harbison D, Ashworth A, Bownes M. 1997a. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): Structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol 7: 776-789.
2. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P. 1997b. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol 7: 261-269.
3. Altomare DA, Guo K, Cheng JQ, Sonoda G, Walsh K, Testa JR. 1995. Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene 11: 1055-1060.
4. Altomare DA, Lyons GE, Mitsuuchi Y, Cheng JQ, Testa JR. 1998. Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulin. Oncogene 16: 2407-2411.
5. Arias EB, Kim J, Funai K, Cartee GD. 2007. Prior exercise increases phosphorylation of Akt substrate of 160kDa (AS160) in rat skeletal muscle. Am J Physiol Endocrinol Metab 292: E1191-E1200.
6. Atherton PJ, Babraj J, Smith K, Singh J, Rennie MJ, Wackerhage H. 2005. Selective activation of AMPK-PGC-1alpha or PKB-TSC2-mTOR signaling can explain specific adaptive responses to endurance or resistance training-like electrical muscle stimulation. FASEB J 19: 786-788.
7. Austin RL, Rune A, Bouzakri K, Zierath JR, Krook A. 2008. siRNA-mediated reduction of inhibitor of nuclear factor-kappaB kinase prevents tumor necrosis factor-alpha-induced insulin resistance in human skeletal muscle. Diabetes 57: 2066-2073.
8. Blaauw B, Mammucari C, Toniolo L, Agatea L, Abraham R, Sandri M, Reggiani C, Schiaffino S. 2008. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle. Hum Mol Genet 17: 3686-3696.
9. Blaauw B, Canato M, Agatea L, Toniolo L, Mammucari C, Masiero E, Abraham R, Sandri M, Schiaffino S, Reggiani C. 2009. Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation. FASEB J 23: 3896-3905.
10. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 3: 1014-1019.
11. Bonkowski MS, Dominici FP, Arum O, Rocha JS, Al Regaiey KA, Westbrook R, Spong A, Panici J, Masternak MM, Kopchick JJ, Bartke A. 2009. Disruption of growth hormone receptor prevents calorie restriction from improving insulin action and longevity. PLoS One 4: e4567.
12. Bouzakri K, Zachrisson A, Al-Khalili L, Zhang BB, Koistinen HA, Krook A, Zierath JR. 2006. siRNA-based gene silencing reveals specialized roles of IRS-1/Akt2 and IRS-2/Akt1 in glucose and lipid metabolism in human skeletal muscle. Cell Metab 4: 89-96.
13. Brand C, Cipok M, Attali V, Bak A, Sampson SR. 2006. Protein kinase Cdelta participates in insulin-induced activation of PKB via PDK1. Biochem Biophys Res Commun 349: 954-962.
14. Brodbeck D, Cron P, Hemmings BA. 1999. A human protein kinase Bgamma with regulatory phosphorylation sites in the activation loop and in the C-terminal hydrophobic domain. J Biol Chem 274: 9133-9136.
15. Brognard J, Sierecki E, Gao T, Newton AC. 2007. PHLPP and a second isoform, PHLPP2, differentially attenuate the amplitude of Akt signaling by regulating distinct Akt isoforms. Mol Cell 25: 917-931.
16. Brozinick JT, Jr., Roberts BR, Dohm GL. 2003. Defective signaling through Akt-2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: Potential role in insulin resistance. Diabetes 52: 935-941.
17. Bruss MD, Arias EB, Lienhard GE, Cartee GD. 2005. Increased phosphorylation of Akt substrate of 160kDa (AS160) in rat skeletal muscle in response to insulin or contractile activity. Diabetes 54: 41-50.
18. Cabane C, Coldefy AS, Yeow K, Derijard B. 2004. The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis. Cell Signal 16: 1405-1415.
19. Calleja V, Alcor D, Laguerre M, Park J, Vojnovic B, Hemmings BA, Downward J, Parker PJ, Larijani B. 2007. Intramolecular and intermolecular interactions of protein kinase B define its activation in vivo. PLoS Biol 5: e95.
20. Carvalho-Filho MA, Ueno M, Hirabara SM, Seabra AB, Carvalheira JB, de Oliveira MG, Velloso LA, Curi R, Saad MJ. 2005. S-nitrosation of the insulin receptor, insulin receptor substrate 1, and protein kinase B/Akt: A novel mechanism of insulin resistance. Diabetes 54: 959-967.
21. Carvalho-Filho MA, Ueno M, Carvalheira JB, Velloso LA, Saad MJ. 2006. Targeted disruption of iNOS prevents LPS-induced S-nitrosation of IRbeta/IRS-1 and Akt and insulin resistance in muscle of mice. Am J Physiol Endocrinol Metab 291: E476-E482.
22. Cen L, Hsieh FC, Lin HJ, Chen CS, Qualman SJ, Lin J. 2007. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound. Br J Cancer 97: 785-791.
23. Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R, Tobe K, Kadowaki T, Hay N. 2001. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev 15: 2203-2208.
24. Cho H, Mu J, Kim JK, Thorvaldsen JL, Chu Q, Crenshaw EB III, Kaestner KH, Bartolomei MS, Shulman GI, Birnbaum MJ. 2001a. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292: 1728-1731.
25. Cho H, Thorvaldsen JL, Chu Q, Feng F, Birnbaum MJ. 2001b. Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem 276: 38349-38352.
26. Cleasby ME, Reinten TA, Cooney GJ, James DE, Kraegen EW. 2007. Functional studies of Akt isoform specificity in skeletal muscle in vivo; maintained insulin sensitivity despite reduced insulin receptor substrate-1 expression. Mol Endocrinol 21: 215-228.
27. Cozzone D, Frojdo S, Disse E, Debard C, Laville M, Pirola L, Vidal H. 2008. Isoform-specific defects of insulin stimulation of Akt/protein kinase B (PKB) in skeletal muscle cells from type 2 diabetic patients. Diabetologia 51: 512-521.
28. Creer A, Gallagher P, Slivka D, Jemiolo B, Fink W, Trappe S. 2005. Influence of muscle glycogen availability on ERK1/2 and Akt signaling after resistance exercise in human skeletal muscle. J Appl Physiol 99: 950-956.
29. Crossland H, Constantin-Teodosiu D, Gardiner SM, Constantin D, Greenhaff PL. 2008. A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle. J Physiol 586: 5589-5600.
30. D'Alessandris C, Lauro R, Presta I, Sesti G. 2007. C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport. Diabetologia 50: 840-849.
31. de Alvaro C, Teruel T, Hernandez R, Lorenzo M. 2004. Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem 279: 17070-17078.
32. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S. 1998. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211-11216.
33. Deldicque L, Atherton P, Patel R, Theisen D, Nielens H, Rennie MJ, Francaux M. 2008. Decrease in Akt/PKB signalling in human skeletal muscle by resistance exercise. Eur J Appl Physiol 104: 57-65.
34. Dokken BB, Saengsirisuwan V, Kim JS, Teachey MK, Henriksen EJ. 2008. Oxidative stress-induced insulin resistance in rat skeletal muscle: Role of glycogen synthase kinase-3. Am J Physiol Endocrinol Metab 294: E615-E621.
35. Easton RM, Cho H, Roovers K, Shineman DW, Mizrahi M, Forman MS, Lee VM, Szabolcs M, de Jong R, Oltersdorf T, Ludwig T, Efstratiadis A, Birnbaum MJ. 2005. Role for Akt3/protein kinase Bgamma in attainment of normal brain size. Mol Cell Biol 25: 1869-1878.
36. Engelman JA. 2009. Targeting PI3K signalling in cancer: Opportunities, challenges and limitations. Nat Rev Cancer 9: 550-562.
37. Falasca M. 2010. PI3K/Akt signalling pathway specific inhibitors: A novel strategy to sensitize cancer cells to anti-cancer drugs. Curr Pharm Des 12: 1410-1416.
38. Falasca M, Chiozzotto D, Godage HY, Mazzoletti M, Riley AM, Previdi S, Potter BV, Broggini M, Maffucci T. 2010. A novel inhibitor of the PI3K/Akt pathway based on the structure of inositol 1, 3, 4, 5, 6-pentakisphosphate. Br J Cancer 102: 104-114.
39. Fecchi K, Volonte D, Hezel MP, Schmeck K, Galbiati F. 2006. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J 20: 705-707.
40. Feng J, Park J, Cron P, Hess D, Hemmings BA. 2004. Identification of a PKB/Akt hydrophobic motif Ser-473 kinase as DNA-dependent protein kinase. J Biol Chem 279: 41189-41196.
41. Funai K, Parkington JD, Carambula S, Fielding RA. 2006. Age-associated decrease in contraction-induced activation of downstream targets of Akt/mTor signaling in skeletal muscle. Am J Physiol Regul Integr Comp Physiol 290: R1080-R1086.
42. Gao T, Furnari F, Newton AC. 2005. PHLPP: A phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18: 13-24.
43. Goodyear LJ, Chang PY, Sherwood DJ, Dufresne SD, Moller DE. 1996. Effects of exercise and insulin on mitogen-activated protein kinase signaling pathways in rat skeletal muscle. Am J Physiol 271: E403-E408.
44. Gosmanov AR, Umpierrez GE, Karabell AH, Cuervo R, Thomason DB. 2004. Impaired expression and insulin-stimulated phosphorylation of Akt-2 in muscle of obese patients with atypical diabetes. Am J Physiol Endocrinol Metab 287: E8-E15.
45. Guillet C, Prod'homme M, Balage M, Gachon P, Giraudet C, Morin L, Grizard J, Boirie Y. 2004. Impaired anabolic response of muscle protein synthesis is associated with S6K1 dysregulation in elderly humans. FASEB J 18: 1586-1587.
46. Gupte AA, Bomhoff GL, Geiger PC. 2008. Age-related differences in skeletal muscle insulin signaling: The role of stress kinases and heat shock proteins. J Appl Physiol 105: 839-848.
47. Haddad F, Adams GR. 2006. Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy. J Appl Physiol 100: 1188-1203.
48. Hajduch E, Alessi DR, Hemmings BA, Hundal HS. 1998. Constitutive activation of protein kinase B alpha by membrane targeting promotes glucose and system A amino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47: 1006-1013.
49. Halseth AE, Bracy DP, Wasserman DH. 2001. Functional limitations to glucose uptake in muscles comprised of different fiber types. Am J Physiol Endocrinol Metab 280: E994-E999.
50. Higaki Y, Mikami T, Fujii N, Hirshman MF, Koyama K, Seino T, Tanaka K, Goodyear LJ. 2008. Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway. Am J Physiol Endocrinol Metab 294: E889-E897.
51. Hilder TL, Tou JC, Grindeland RE, Wade CE, Graves LM. 2003. Phosphorylation of insulin receptor substrate-1 serine 307 correlates with JNK activity in atrophic skeletal muscle. FEBS Lett 553: 63-67.
52. Hsieh CC, Papaconstantinou J. 2004. Akt/PKB and p38 MAPK signaling, translational initiation and longevity in Snell dwarf mouse livers. Mech Ageing Dev 125: 785-798.
53. Izumiya Y, Hopkins T, Morris C, Sato K, Zeng L, Viereck J, Hamilton JA, Ouchi N, LeBrasseur NK, Walsh K. 2008. Fast/Glycolytic muscle fiber growth reduces fat mass and improves metabolic parameters in obese mice. Cell Metab 7: 159-172.
54. Kappler R, Calzada-Wack J, Schnitzbauer U, Koleva M, Herwig A, Piontek G, Graedler F, Adamski J, Heinzmann U, Schlegel J, Hemmerlein B, Quintanilla-Martinez L, Hahn H. 2003. Molecular characterization of Patched-associated rhabdomyosarcoma. J Pathol 200: 348-356.
55. Kapur S, Bedard S, Marcotte B, Cote CH, Marette A. 1997. Expression of nitric oxide synthase in skeletal muscle: A novel role for nitric oxide as a modulator of insulin action. Diabetes 46: 1691-1700.
56. Katta A, Kakarla S, Wu M, Paturi S, Gadde MK, Arvapalli R, Kolli M, Rice KM, Blough ER. 2009a. Altered regulation of contraction-induced Akt/mTOR/p70S6k pathway signaling in skeletal muscle of the obese Zucker rat. Exp Diabetes Res 384683.
57. Katta A, Karkala SK, Wu M, Meduru S, Desai DH, Rice KM, Blough ER. 2009b. Lean and obese Zucker rats exhibit different patterns of p70s6 kinase regulation in the tibialis anterior muscle in response to high-force muscle contraction. Muscle Nerve 39: 503-511.
58. Keniry M, Parsons R. 2008. The role of PTEN signaling perturbations in cancer and in targeted therapy. Oncogene 27: 5477-5485.
59. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ. 2004. Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 24: 9295-9304.
60. Lemmon MA, Falasca M, Ferguson KM, Schlessinger J. 1997. Regulatory recruitment of signalling molecules to the cell membrane by pleckstrin homology domains. Trends Cell Biol 7: 237-242.
61. Leslie NR, Batty IH, Maccario H, Davidson L, Downes CP. 2008. Understanding PTEN regulation: PIP2, polarity and protein stability. Oncogene 27: 5464-5476.
62. Lessard SJ, Rivas DA, Chen ZP, Bonen A, Febbraio MA, Reeder DW, Kemp BE, Yaspelkis BB III, Hawley JA. 2007. Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance. Diabetes 56: 1856-1864.
63. Lin K, Hsin H, Libina N, Kenyon C. 2001. Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/IGF-1 and germline signaling. Nat Genet 28: 139-145.
64. Maffucci T, Falasca M. 2001. Specificity in pleckstrin homology (PH) domain membrane targeting: A role for a phosphoinositide-protein co-operative mechanism. FEBS Lett 506: 173-179.
65. Maffucci T, Piccolo E, Cumashi A, Iezzi M, Riley AM, Saiardi A, Godage HY, Rossi C, Broggini M, Iacobelli S, Potter BV, Innocenti P, Falasca M. 2005. Inhibition of the phosphatidylinositol 3-kinase/Akt pathway by inositol pentakisphosphate results in antiangiogenic and antitumor effects. Cancer Res 65: 8339-8349.
66. Martin D, Salinas M, Fujita N, Tsuruo T, Cuadrado A. 2002. Ceramide and reactive oxygen species generated by H2O2 induce caspase-3-independent degradation of Akt/protein kinase B. J Biol Chem 277: 42943-42952.
67. Matheny RW, Jr., Adamo ML. 2009. Effects of PI3K catalytic subunit and Akt isoform deficiency on mTOR and p70S6K activation in myoblasts. Biochem Biophys Res Commun 2: 252-257.
68. McCurdy CE, Cartee GD. 2005. Akt2 is essential for the full effect of calorie restriction on insulin-stimulated glucose uptake in skeletal muscle. Diabetes 54: 1349-1356.
69. Meyer C, Dostou JM, Welle SL, Gerich JE. 2002. Role of human liver, kidney, and skeletal muscle in postprandial glucose homeostasis. Am J Physiol Endocrinol Metab 282: E419-E427.
70. Miyauchi H, Minamino T, Tateno K, Kunieda T, Toko H, Komuro I. 2004. Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway. EMBO J 23: 212-220.
71. Moore T, Beltran L, Carbajal S, Strom S, Traag J, Hursting SD, DiGiovanni J. 2008. Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues. Cancer Prev Res (Phila, PA) 1: 65-76.
72. Nakatani K, Sakaue H, Thompson DA, Weigel RJ, Roth RA. 1999. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys Res Commun 257: 906-910.
73. Ouchi N, Oshima Y, Ohashi K, Higuchi A, Ikegami C, Izumiya Y, Walsh K. 2008. Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem 283: 32802-32811.
74. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM, Schiaffino S. 2002. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proc Natl Acad Sci USA 99: 9213-9218.
75. Paturi S, Gutta AK, Katta A, Kakarla SK, Arvapalli RK, Gadde MK, Nalabotu SK, Rice KM, Wu M, Blough E. 2010. Effects of aging and gender on muscle mass and regulation of Akt-mTOR-p70s6k related signaling in the F344BN rat model. Mech Ageing Dev 131: 202-209.
76. Peng XD, Xu PZ, Chen ML, Hahn-Windgassen A, Skeen J, Jacobs J, Sundararajan D, Chen WS, Crawford SE, Coleman KG, Hay N. 2003. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev 17: 1352-1365.
77. Petricoin EF, III, Espina V, Araujo RP, Midura B, Yeung C, Wan X, Eichler GS, Johann DJ, Jr., Qualman S, Tsokos M, Krishnan K, Helman LJ, Liotta LA. 2007. Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival. Cancer Res 67: 3431-3440.
78. Planavila A, Alegret M, Sanchez RM, Rodriguez-Calvo R, Laguna JC, Vazquez-Carrera M. 2005. Increased Akt protein expression is associated with decreased ceramide content in skeletal muscle of troglitazone-treated mice. Biochem Pharmacol 69: 1195-1204.
79. Proctor DN, O'Brien PC, Atkinson EJ, Nair KS. 1999. Comparison of techniques to estimate total body skeletal muscle mass in people of different age groups. Am J Physiol 277: E489-E495.
80. Randle PJ, Garland PB, Hales CN, Newsholme EA. 1963. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1: 785-789.
81. Rotwein P, Wilson EM. 2009. Distinct actions of Akt1 and Akt2 in skeletal muscle differentiation. J Cell Physiol 219: 503-511.
82. Russell ST, Eley HL, Wyke SM, Tisdale MJ. 2008. Involvement of phosphoinositide 3-kinase and Akt in the induction of muscle protein degradation by proteolysis-inducing factor. Biochem J 409: 751-759.
83. Sakamoto K, Arnolds DE, Fujii N, Kramer HF, Hirshman MF, Goodyear LJ. 2006. Role of Akt2 in contraction-stimulated cell signaling and glucose uptake in skeletal muscle. Am J Physiol Endocrinol Metab 291: E1031-E1037.
84. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412.
85. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM. 2005. Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307: 1098-1101.
86. Shepherd PR, Withers DJ, Siddle K. 1998. Phosphoinositide 3-kinase: The key switch mechanism in insulin signalling. Biochem J 333: 471-490.
87. Takahashi A, Kureishi Y, Yang J, Luo Z, Guo K, Mukhopadhyay D, Ivashchenko Y, Branellec D, Walsh K. 2002. Myogenic Akt signaling regulates blood vessel recruitment during myofiber growth. Mol Cell Biol 22: 4803-4814.
88. Troussard AA, McDonald PC, Wederell ED, Mawji NM, Filipenko NR, Gelmon KA, Kucab JE, Dunn SE, Emerman JT, Bally MB, Dedhar S. 2006. Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival. Cancer Res 66: 393-403.
89. Ueki K, Yamamoto-Honda R, Kaburagi Y, Yamauchi T, Tobe K, Burgering BM, Coffer PJ, Komuro I, Akanuma Y, Yazaki Y, Kadowaki T. 1998. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem 273: 5315-5322.
90. Wan X, Helman LJ. 2003. Levels of PTEN protein modulate Akt phosphorylation on serine 473, but not on threonine 308, in IGF-II-overexpressing rhabdomyosarcomas cells. Oncogene 22: 8205-8211.
91. Wijesekara N, Konrad D, Eweida M, Jefferies C, Liadis N, Giacca A, Crackower M, Suzuki A, Mak TW, Kahn CR, Klip A, Woo M. 2005. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Mol Cell Biol 3: 1135-1145.
92. Wilson EM, Rotwein P. 2007. Selective control of skeletal muscle differentiation by Akt1. J Biol Chem 282: 5106-5110.
93. Wretman C, Lionikas A, Widegren U, Lannergren J, Westerblad H, Henriksson J. 2001. Effects of concentric and eccentric contractions on phosphorylation of MAPK(erk1/2) and MAPK(p38) in isolated rat skeletal muscle. J Physiol 535: 155-164.
94. Wu M, Desai DH, Kakarla SK, Katta A, Paturi S, Gutta AK, Rice KM, Walker EM Jr, Blough ER. 2009a. Acetaminophen prevents aging-associated hyperglycemia in aged rats: Effect of aging-associated hyperactivation of p38-MAPK and ERK1/2. Diabetes Metab Res Rev 25: 279-286.
95. Wu M, Fannin J, Rice KM, Wang B, Blough ER. 2009b. Effect of aging on cellular mechanotransduction. Ageing Res Rev. Article in Press, doi: 10.1016/j.arr.2009.11.002
96. Wu M, Katta A, Gadde MK, Liu H, Kakarla SK, Fannin J, Paturi S, Arvapalli RK, Rice KM, Wang Y, Blough ER. 2009c. Aging-associated dysfunction of akt/protein kinase B: s-Nitrosylation and acetaminophen intervention. PLoS One 4: e6430.
97. Wu M, Liu H, Fannin J, Katta A, Wang Y, Arvapalli RK, Paturi S, Kakarla SK, Rice KM, Blough ER. 2010a. Acetaminophen improves protein translational signaling in aged skeletal muscle. Rejuvenation Res 13, in press.
98. Wu M, Wang B, Fei J, Santanam N, Blough ER. 2010b. Important roles of Akt/PKB signaling in the aging process. Front Biosci (Scholar Ed) 2: 1169-1188.
99. Yasukawa T, Tokunaga E, Ota H, Sugita H, Martyn JA, Kaneki M. 2005. S-Nitrosylation-dependent inactivation of Akt/protein kinase B in insulin resistance. J Biol Chem 280: 7511-7518.